Insufficient scRNA-seq data for expression of EPHB3 at single-cell level.
Insufficient scRNA-seq data for expression of EPHB3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 98% | 2238.67 | 241 / 245 | 96% | 39.92 | 481 / 502 |
ovary | 98% | 1707.34 | 176 / 180 | 85% | 47.46 | 364 / 430 |
uterus | 96% | 2251.18 | 163 / 170 | 83% | 63.98 | 379 / 459 |
stomach | 91% | 3402.97 | 328 / 359 | 87% | 83.08 | 248 / 286 |
pancreas | 90% | 1531.97 | 296 / 328 | 80% | 24.86 | 143 / 178 |
intestine | 77% | 1267.03 | 742 / 966 | 92% | 133.22 | 483 / 527 |
esophagus | 69% | 2313.86 | 991 / 1445 | 89% | 68.70 | 163 / 183 |
breast | 59% | 1936.05 | 270 / 459 | 95% | 73.53 | 1062 / 1118 |
lung | 64% | 559.38 | 371 / 578 | 78% | 46.27 | 905 / 1155 |
bladder | 71% | 703.29 | 15 / 21 | 68% | 54.08 | 342 / 504 |
skin | 82% | 7047.72 | 1477 / 1809 | 49% | 22.82 | 233 / 472 |
brain | 46% | 601.47 | 1218 / 2642 | 76% | 22.22 | 539 / 705 |
tonsil | 0% | 0 | 0 / 0 | 84% | 49.70 | 38 / 45 |
thymus | 3% | 18.70 | 18 / 653 | 56% | 14.66 | 338 / 605 |
kidney | 22% | 232.85 | 20 / 89 | 3% | 1.16 | 25 / 901 |
eye | 0% | 0 | 0 / 0 | 23% | 5.29 | 18 / 80 |
adipose | 22% | 207.89 | 264 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 17% | 131.70 | 224 / 1335 | 0% | 0 | 0 / 0 |
heart | 10% | 72.39 | 87 / 861 | 0% | 0 | 0 / 0 |
liver | 2% | 11.24 | 4 / 226 | 6% | 3.27 | 25 / 406 |
adrenal gland | 2% | 10.33 | 4 / 258 | 3% | 0.63 | 6 / 230 |
spleen | 4% | 25.00 | 9 / 241 | 0% | 0 | 0 / 0 |
muscle | 1% | 9.86 | 10 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 1.09 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001525 | Biological process | angiogenesis |
GO_0048013 | Biological process | ephrin receptor signaling pathway |
GO_0060997 | Biological process | dendritic spine morphogenesis |
GO_0001655 | Biological process | urogenital system development |
GO_0022407 | Biological process | regulation of cell-cell adhesion |
GO_0007413 | Biological process | axonal fasciculation |
GO_0060021 | Biological process | roof of mouth development |
GO_0021952 | Biological process | central nervous system projection neuron axonogenesis |
GO_0060996 | Biological process | dendritic spine development |
GO_0034446 | Biological process | substrate adhesion-dependent cell spreading |
GO_0043087 | Biological process | regulation of GTPase activity |
GO_0048538 | Biological process | thymus development |
GO_0022038 | Biological process | corpus callosum development |
GO_0006468 | Biological process | protein phosphorylation |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0031290 | Biological process | retinal ganglion cell axon guidance |
GO_0051965 | Biological process | positive regulation of synapse assembly |
GO_0048546 | Biological process | digestive tract morphogenesis |
GO_0016477 | Biological process | cell migration |
GO_0007411 | Biological process | axon guidance |
GO_0050770 | Biological process | regulation of axonogenesis |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0030425 | Cellular component | dendrite |
GO_0005829 | Cellular component | cytosol |
GO_0008046 | Molecular function | axon guidance receptor activity |
GO_0005003 | Molecular function | ephrin receptor activity |
GO_0005005 | Molecular function | transmembrane-ephrin receptor activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | EPHB3 |
Protein name | Ephrin type-B receptor 3 (EC 2.7.10.1) (EPH-like tyrosine kinase 2) (EPH-like kinase 2) (Embryonic kinase 2) (EK2) (hEK2) (Tyrosine-protein kinase TYRO6) |
Synonyms | ETK2 HEK2 TYRO6 |
Description | FUNCTION: Receptor tyrosine kinase which binds promiscuously transmembrane ephrin-B family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Generally has an overlapping and redundant function with EPHB2. Like EPHB2, functions in axon guidance during development regulating for instance the neurons forming the corpus callosum and the anterior commissure, 2 major interhemispheric connections between the temporal lobes of the cerebral cortex. In addition to its role in axon guidance also plays an important redundant role with other ephrin-B receptors in development and maturation of dendritic spines and the formation of excitatory synapses. Controls other aspects of development through regulation of cell migration and positioning. This includes angiogenesis, palate development and thymic epithelium development for instance. Forward and reverse signaling through the EFNB2/EPHB3 complex also regulate migration and adhesion of cells that tubularize the urethra and septate the cloaca. Finally, plays an important role in intestinal epithelium differentiation segregating progenitor from differentiated cells in the crypt. . |
Accessions | ENST00000330394.3 P54753 |